These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11070569)

  • 21. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of statins in coronary heart disease.
    Franco OH; Peeters A; Looman CW; Bonneux L
    J Epidemiol Community Health; 2005 Nov; 59(11):927-33. PubMed ID: 16234419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of intensive statin therapy in the elderly.
    Maroo BP; Lavie CJ; Milani RV
    Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early statin treatment in acute coronary syndrome. Is this evidence-based?].
    Jensen LO; Hansen HS
    Ugeskr Laeger; 2002 Jul; 164(27):3519-22. PubMed ID: 12116678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of coronary heart disease with statins. Which patients profit?].
    Adam O; Forth W
    MMW Fortschr Med; 2003 Jun; 145(25):37-40. PubMed ID: 12891851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do the statin trials tell us?
    Waters DD
    Am J Manag Care; 2001 May; 7(5 Suppl):S138-43. PubMed ID: 11383375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective].
    Klever-Deichert G; Hinzpeter B; Wendland G; Lauterbach K
    Med Klin (Munich); 2000 Jun; 95(6):305-13. PubMed ID: 10935414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute coronary syndrome in primary health care].
    Macedo A; Rosa F
    Acta Med Port; 2010; 23(2):213-22. PubMed ID: 20470468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What role for statins? A review and economic model.
    Ebrahim S; Davey Smith G; McCabe C; Payne N; Pickin M; Sheldon TA; Lampe F; Sampson F; Ward S; Wannamethee G
    Health Technol Assess; 1999; 3(19):i-iv, 1-91. PubMed ID: 10576067
    [No Abstract]   [Full Text] [Related]  

  • 38. Changing the practice of cardiovascular medicine.
    Braunwald E
    Atheroscler Suppl; 2001 Feb; 2(1):27-30. PubMed ID: 11286153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical progress and rationing of cardiological services.
    Kreuzer J; Kübler W
    Z Kardiol; 2000; 89 Suppl 4():IV61-7. PubMed ID: 10810778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of patterns of drug therapy in Hungary and in developed Western countries for acute coronary syndromes].
    Keltai M
    Orv Hetil; 2000 Jun; 141(26):1449-53. PubMed ID: 10936933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.